Home › Funds › ARBOR TRUST WEALTH ADVISORS, LLC › ABT

ARBOR TRUST WEALTH ADVISORS, LLC position in ABT

ABBOTT LABORATORIES · Health Care

ARBOR TRUST WEALTH ADVISORS, LLC reported holding 44,362 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 1.70% of its reported portfolio and ranking #21 among its reported holdings. ARBOR TRUST WEALTH ADVISORS, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)44.36K sh
Reported value held$4.38M
Portfolio Weight1.70%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ARBOR TRUST WEALTH ADVISORS, LLC's ABT position evolved

ARBOR TRUST WEALTH ADVISORS, LLC first disclosed a stake in ABT in Q3 2023 at 49,197 shares (US$4.8M). The position peaked in Q2 2025 at 47,336 shares, worth US$6.4M. Across 13 filings, ARBOR TRUST WEALTH ADVISORS, LLC increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 44,362 shares valued at US$4.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 49.20K $4.76M New
Q4 2023 49.29K $5.43M Hold
Q1 2024 48.58K $5.40M Reduce
Q2 2024 48.10K $5.00M Reduce
Q3 2024 48.10K $5.00M Hold
Q4 2024 47.16K $5.33M Reduce
Q1 2025 47.38K $6.29M Hold
Q2 2025 47.34K $6.44M Hold
Q3 2025 47.02K $6.30M Reduce
Q4 2025 46.64K $5.84M Reduce
Q1 2026 44.74K $4.59M Reduce
Q2 2026 44.23K $4.01M Reduce
Q3 2026 44.36K $4.38M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has ARBOR TRUST WEALTH ADVISORS, LLC held ABT?

ARBOR TRUST WEALTH ADVISORS, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ARBOR TRUST WEALTH ADVISORS, LLC's current position in ABT?

As of Q3 2026, ARBOR TRUST WEALTH ADVISORS, LLC holds 44.36K shares of ABT (ABBOTT LABORATORIES), valued at $4.38M, representing 1.70% of its reported portfolio and ranking #21.

Has ARBOR TRUST WEALTH ADVISORS, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), ARBOR TRUST WEALTH ADVISORS, LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 47.34K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.